Niranjan Kanesa-thasan - Jul 28, 2021 Form 3 Insider Report for Icosavax, Inc. (ICVX)

Role
Chief Medical Officer
Signature
/s/ Thomas Russo, Attorney-in Fact
Stock symbol
ICVX
Transactions as of
Jul 28, 2021
Transactions value $
$0
Form type
3
Date filed
7/28/2021, 09:23 PM
Next filing
Aug 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ICVX Common Stock 120K Jul 28, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ICVX Stock Option (Right to Buy) Jul 28, 2021 Common Stock 30.1K $0.83 Direct F2
holding ICVX Stock Option (Right to Buy) Jul 28, 2021 Common Stock 156K $1.04 Direct F3
holding ICVX Stock Option (Right to Buy) Jul 28, 2021 Common Stock 120K $5.90 Direct F4
holding ICVX Stock Option (Right to Buy) Jul 28, 2021 Common Stock 125K $15.00 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 53,623 shares subject to repurchase by us, which are subject to vesting.
F2 25% of the shares subject to the option vested on 4/1/2021, and 1/48th of the shares subject to the option vest monthly thereafter.
F3 25% of the shares subject to the option will vest on 1/14/2022, and 1/48th of the shares subject to the option vest monthly thereafter.
F4 25% of the shares subject to the option will vest on 3/19/2022, and 1/48th of the shares subject to the option vest monthly thereafter.
F5 1/48th of the shares subject to the option vest monthly following July 28, 2021, the vesting commencement date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney